We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Porvair Sciences to Feature on Sky TV

Porvair Sciences to Feature on Sky TV content piece image
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute
Porvair was chosen to be part of a documentary that’s set to be broadcast on Sunday 7 January 2018 at 10am. Entitled ‘Products to Benefit Healthcare’ the programme was filmed in August 2017 at Porvair Sciences facility in Wrexham, North Wales, and will be shown on Sky Digital channel 189.

The Sky TV documentary features prominent on-screen contributions from General Manager Kevin Doolan and Head of New Product Development Dr David Cowieson.

Both discuss the application of filter technology in the healthcare sector, from specialised components for use in medical devices, the introduction of particulate-free environments in clean rooms that are necessary for cGMP manufacturing, to the clean-up and containing of waste products created during the manufacturing process in the clinical workplace. The evolution of the company to enable delivery of high performance products acting at the centre of critically controlled healthcare processes using a Class 10000 clean room on the Wrexham site is also discussed.

Kevin Doolan said: “We are very proud of what we do here. Our UK site is the global R&D and manufacturing centre for our BioVyon™ porous plastic materials. It is where we design, develop and engineer our new products – and is the centre of excellence for our life science and healthcare sector offerings. Naturally we were delighted to receive TV exposure for this side of the business. It is a testament to our status as pioneers in our field that our processes are of interest to such a wide audience, recognizing our tireless efforts to innovate, develop, manufacture and provide the best products and services for the global life science and healthcare market.”